Tourniquet-Test in HHT
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 92
- 试验地点
- 2
- 主要终点
- number of positive Tourniquet Test results in HHT patients
研究概览
简要总结
The Tourniquet test is used as a diagnostic procedure for thrombocytopathies and vascular diseases. Currently, there is no evidence whether this test is also positive in hereditary haemorrhagic telangiectasia (HHT), a vasculopathy. The aim of this study was to investigate whether this non-invasive test could also be used as an additional diagnostic criterion in patients with HHT.
详细描述
The Tourniquet test is used as a diagnostic procedure for thrombocytopathies and vascular diseases. Currently, there is no evidence whether this test is also positive in hereditary haemorrhagic telangiectasia (HHT), a vasculopathy. The aim of this study was to investigate whether this non-invasive test could also be used as an additional diagnostic criterion in patients with HHT.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •In patients with confirmed HHT diagnosis (≥ 3 Curaçao criteria or positive molecular genetics)
- •aged over 18 years
排除标准
- •if inclusion criteria does not apply
研究组 & 干预措施
Tourniquet Test
Patients with HHT patients who undergo the Tourniquet Test
干预措施: Tourniquet Test (Diagnostic Test)
结局指标
主要结局
number of positive Tourniquet Test results in HHT patients
时间窗: three years
Documentation of the number of positive Tourniquet Test results in HHT patients
次要结局
未报告次要终点
研究者
Freya Droege
Principal Investigator
University Hospital, Essen